Main menu button

News

Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
17 May 2024
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
Equity Research Nosa Plugs
Carlsquare advised on the debt financing of UG Healthcare Corporation Ltd.’s acquisition of German distribution company Unigloves GmbH
16 May 2024
Carlsquare advised on the debt financing of UG Healthcare Corporation Ltd.’s acquisition of German distribution company Unigloves GmbH
Deal News
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
16 May 2024
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
Equity Research
Equity Research GIAB Q1 2024: Slightly higher sales, but new savings needed
16 May 2024
Equity Research GIAB Q1 2024: Slightly higher sales, but new savings needed
Equity Research
Equity research Viva Wine Group, Q1 2024: Profitability above our expectations despite soft top-line
16 May 2024
Equity research Viva Wine Group, Q1 2024: Profitability above our expectations despite soft top-line
Equity Research Viva Wine Group
Equity research HANZA Q1, 2024: Temporarily in a lower orbit
15 May 2024
Equity research HANZA Q1, 2024: Temporarily in a lower orbit
Equity Research Hanza
Carlsquare weekly market letter: Interest rates at a crossroads - will affect the whole market
15 May 2024
Carlsquare weekly market letter: Interest rates at a crossroads - will affect the whole market
Equity Research Carlsquare
Equity Research InCoax, Q1 2024: Strong start to 2024
10 May 2024
Equity Research InCoax, Q1 2024: Strong start to 2024
Equity Research InCoax
This was the OMR24 After-Event in Hamburg
08 May 2024
This was the OMR24 After-Event in Hamburg
Events
Equity Research Svenska Aerogel, Q1 2024: Streamlining to reduce costs
08 May 2024
Equity Research Svenska Aerogel, Q1 2024: Streamlining to reduce costs
Equity Research Svenska Aerogel
Carlsquare weekly market letter: Sell in May and stay away?
08 May 2024
Carlsquare weekly market letter: Sell in May and stay away?
Equity Research Carlsquare
Carlsquare OMR24 After-Event
07 May 2024
Carlsquare OMR24 After-Event
Events
First Impression InCoax Q1 2024: Much better sales and results than expected
07 May 2024
First Impression InCoax Q1 2024: Much better sales and results than expected
Equity Research InCoax
Equity research HANZA: First impression Q1 2024
07 May 2024
Equity research HANZA: First impression Q1 2024
Equity Research Hanza
Carlsquare advised business messaging expert LEKAB on its merger with Norwegian competitor Eurobate
07 May 2024
Carlsquare advised business messaging expert LEKAB on its merger with Norwegian competitor Eurobate
Deal News
With 2024 set to be a strong IPO year, the highly innovative life sciences industry is well-positioned to capitalize
06 May 2024
With 2024 set to be a strong IPO year, the highly innovative life sciences industry is well-positioned to capitalize
Insights
Equity Research Svenska Aerogel, Q1 2024: Increasing effectivity and pilot order from key client
03 May 2024
Equity Research Svenska Aerogel, Q1 2024: Increasing effectivity and pilot order from key client
Equity Research Svenska Aerogel
Equity Research Enrad, Q1 2024: Better than expected start to 2024
02 May 2024
Equity Research Enrad, Q1 2024: Better than expected start to 2024
Equity Research Enrad
Equity research Viva Wine Group, Q1 2024: Solid growth but at modest margins
02 May 2024
Equity research Viva Wine Group, Q1 2024: Solid growth but at modest margins
Equity Research Viva Wine Group
Equity research, HANZA: Preview Q1 2024
30 Apr 2024
Equity research, HANZA: Preview Q1 2024
Equity Research Hanza